VERU INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
VERU INC. (VERU) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 198.75 thousand shares as of 2017-09-30, per its 10-K filed 2018-01-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2018-01-02
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 198.75K shares.
- 2016-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 189.97K shares.
- 2015-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 283.72K shares.
- 2014-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 141.44K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2017-09-30 | 198.75K shares 10-K · filed 2018-01-02 |
| 2016-09-30 | 189.97K shares 10-K · filed 2018-01-02 |
| 2015-09-30 | 283.72K shares 10-K · filed 2018-01-02 |
| 2014-09-30 | 141.44K shares 10-K · filed 2018-01-02 |
| 2013-09-30 | 33.50K shares 10-K · filed 2016-12-12 |
| 2012-09-30 | 93.82K shares 10-K · filed 2015-12-02 |
| 2011-09-30 | 193.50K shares 10-K · filed 2014-12-02 |
| 2010-09-30 | 44.59K shares 10-K · filed 2013-12-03 |
| 2009-09-30 | 119.59K shares 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |